|
Lopez-Galvez R, Rivera-Caravaca JM. Growth Differentiation Factor 15 in Cardiovascular Diseases: Predicting Bleeding after Cardiac Surgery and Beyond That! Thromb Haemost. 2022 May;122(5):657-660. doi: 10.1055/a-1768-4206. Epub 2022 May 5. No abstract available. PubMed PMID: 35144304.
AÑO: 2022; IF: 6.7
|
|
Garcia-Tudela A, Simonelli-Munoz AJ, Rivera-Caravaca JM, Fortea MI, Simon-Sanchez L, Gonzalez-Moro MTR, Gonzalez-Moro JMR, Jimenez-Rodriguez D, Gallego-Gomez JI. Stress in Emergency Healthcare Professionals: The Stress Factors and Manifestations Scale. Int J Environ Res Public Health. 2022 Apr 5;19(7):4342. doi: 10.3390/ijerph19074342. PubMed PMID: 35410024; PubMed Central PMCID: PMC8998299.
AÑO: 2022; IF: 4.614
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Ruiz-Ortiz M, Muniz J, Roldan-Rabadan I, Otero D, Lopez-Galvez R, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F; FANTASIIA investigators. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. Expert Opin Pharmacother. 2022 Aug;23(12):1457-1465. doi: 10.1080/14656566.2022.2109961. Epub 2022 Aug 12. PubMed PMID: 35924672.
AÑO: 2022; IF: 3.2
|
|
Rivera-Caravaca JM, Ding WY, Marin F, Roldan V, Lip GYH; Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc. Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. Eur J Intern Med. 2022 Apr;98:122-124. doi: 10.1016/j.ejim.2021.12.014. Epub 2021 Dec 21. No abstract available. PubMed PMID: 34952769.
AÑO: 2022; IF: 8.0
|
|
Gil-Perez P, Ruiz-Nodar JM, Esteve-Pastor MA, Hortelano I, Villamia B, Vicente-Ibarra N, Orenes-Pinero E, Macias MJ, Nunez-Martinez L, Carrillo L, Candela E, Veliz-Martinez A, Lopez-Garcia C, Martinez-Martinez JG, Rivera-Caravaca JM, Marin F. Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors. Diabetes Res Clin Pract. 2022 Feb;184:109215. doi: 10.1016/j.diabres.2022.109215. Epub 2022 Jan 24. PubMed PMID: 35085647.
AÑO: 2022; IF: 5.1
|
35144304